4//SEC Filing
Steiner Robert D 4
Accession 0001654954-17-008693
CIK 0001069308other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 5:28 PM ET
Size
5.8 KB
Accession
0001654954-17-008693
Insider Transaction Report
Form 4
Steiner Robert D
Chief Medical Officer
Transactions
- Other
Nonqualified Stock Option (right to buy)
2017-09-19+40,000→ 40,000 totalExercise: $2.55Exp: 2026-04-05→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Received in connection with the Issuer's business combination (the "Merger") with what was then known as "Acer Therapeutics Inc." ("Private Acer") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated June 30, 2017 among the Issuer, Opexa Merger Sub, Inc. and Private Acer, in exchange for an option to acquire 40,000 shares of common stock of Private Acer.
- [F2]Option vests in eight equal quarterly installments beginning on January 1, 2016.
Documents
Issuer
Acer Therapeutics Inc.
CIK 0001069308
Entity typeother
Related Parties
1- filerCIK 0001717553
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 5:28 PM ET
- Size
- 5.8 KB